Rezultati
eNauka >
Results >
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2
| Title: | Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2 | Authors: | Goel, Shom; Tan, Antoinette R; Rugo, Hope S; Aftimos, Philippe; Andric, Zoran G   ; Beelen, Andrew Paul; Zhang, Jingshan; Yi, John S; Malik, Rajesh K; O'Shaughnessy, Joyce |
Issue Date: | 2022 | Publication: | FUTURE ONCOLOGY | ISSN: | 1479-6694 Future Oncology Search Idenfier |
Type: | Article | Collation: | vol. 18 br. 33 str. 3701-3711 | DOI: | 10.2217/fon-2022-0773 | WoS-ID: | 000859830500001 | Scopus-ID: | 2-s2.0-85144598674 | URI: | https://enauka.gov.rs/handle/123456789/810883 | Project: | G1 Therapeutics Eli Lilly Merck Pfizer AstraZeneca Ayala Boehringer Ingelheim Daiichi Gilead Lilly Macrogenics Novartis OBI Odonate Polyphor Roche Seattle Genetics Sermonix |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 22M22 |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.